With experience representing an array of biotechnology and pharmaceutical clients across different industry sectors, our intellectual property professionals have met head-on the unique challenges to gaining patent protection for innovations in these fields. Working closely with the innovators and the Patent Office, our intellectual property professionals have gained invaluable insight into the now commonplace patent-eligibility and written description challenges and how to address them. Having technical expertise in a wide area of disciplines within the biotechnology and pharmaceutical industries, our intellectual property professionals have the legal and technical knowledge needed to bridge the gap between innovators and the Patent Office. Our intellectual property professionals also keep abreast of legal decisions and changing standards in the Patent Office, enabling them to provide strategy and portfolio management options tailored to the individual needs of the client as well as to the changing legal landscape.
Having worked closely with several research and academic institutions, as well as corporations and start-up companies in the biotechnology and pharmaceutical spaces, our intellectual property professionals have the technical know-how and enthusiasm necessary to work with cutting edge technologies. With extensive training in life sciences and chemistry, Lewis Roca Rothgerber Christie professionals have a wealth of intellectual property experience in a wide variety of biotechnology and pharmaceutical disciplines, including therapeutics, pharmaceuticals, diagnostics, genetics, genetic engineering, stem cell methodologies, antibodies, transgenic animals, cosmetics and cosmeceuticals, nutraceuticals, and dietary supplements, to name a few. Given our breadth of technical expertise, we at Lewis Roca Rothgerber Christie pride ourselves on leveraging that knowledge to gain meaningful protection for our clients’ intellectual property.